Dr. Hamilton (Erika Hamilton, MD) presents initial Phase 1 dose escalation data for Em-Le. The study concluded that "based on the initial reported data, Emi-Le appears to have encouraging clinical activity and tolerability in a heavily pretreated population." Antonio Giordano, MD PhD

Emiltatug-ledadotin, B7-H4 ADC, auristatin💣DAR 6, dose escalation, showed activity in TNBC previously treated with Topo-1 ADC, and ACC-I #ASCO25 - TNBC ORR 23% (3/13) - ORR 🆙 with high B7-H4 - ACC-I ORR 56% (u+cPR) Trial expanding in TNBC 1-4L post ADC-top1 Dana-Farber’s Breast Oncology Center

🔔Practice change alert for breast cancer physicians #bcsm ‼️Schedule your K522 and ascent-04 pts in the morning‼️ Randomized clinical trial shows improved OS…HR 0.45, for lung ca patients receiving NACT with immunotherapy in the morning #ASCO25 Harold J. Burstein, MD, PhD, FASCO

15 Posts Not to Miss from the 4th Day of ASCO 2025 Antonio Giordano, MD PhD | Armando Orlandi | Arndt Vogel | Elvina Almuradova | Giannis Mountzios | Kimryn Rathmell | Paolo Tarantino | Pashtoon Kasi MD, MS | Robin Zon | Shankar Siva | Sibylle Loibl | Wafik S. El-Deiry, MD, PhD, FACP oncodaily.com/societies/asco… #ASCO #ASCO2025

Another highlight of #ASCO2025: reconnecting with my mentors and colleagues. Dana-Farber’s Breast Oncology Center Sara Tolaney Dr Sarah Sammons Paolo Tarantino Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Antonio Giordano, MD PhD Erica Mayer Stefania Morganti, MD Nancy Lin, MD

Dream team breast cancer researchers Dana-Farber’s Breast Oncology Center Dana-Farber pioneering advancement therapeutics for patients #bcsm ASCO Sara Tolaney Ann Partridge MD, MPH Harold J. Burstein, MD, PhD, FASCO Nancy Lin, MD Erica Mayer Dr Sarah Sammons Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Ada Waks Heather Parsons Ilana Schlam Elahe Salehi DNP Paolo Tarantino

Check out this recent review on the management of metastatic hormone receptor-positive #BreastCancer Beyond CDK4/6 Inhibitors. 🔓pubmed.ncbi.nlm.nih.gov/40434676/ ✍️Antonio Giordano, MD PhD Erica Mayer Sara Tolaney Paolo Tarantino Ilana Schlam @AnaGarridoCastro

🚨 If you're as serious about breast cancer care as Reshma Mahtani, Alan Baik, Antonio Giordano, MD PhD, Stephanie Graff, MD, FACP, FASCO, Claudine Isaacs, Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸, Heather McArthur, MD, MPH, FASCO, Kelly McCann, MD, PhD, Olufunmilayo Olopade, Kristin E. Rojas MD, FACS, FACOG, Dr Sarah Sammons, Rebecca Shatsky, MD, Joyce O'Shaughnessy, MD then you won't miss #PBCCLive25 in DC! It's the

Such an honor to have Dr. Beatrice Wiafe-Addai visiting Dana-Farber for few days. Interesting prospective of cancer care from 🇬🇭 Ghana where drug armamentarium is so limited. #cancerdisparity #westafrica Dana-Farber News Dana-Farber’s Breast Oncology Center

Antonio Giordano, MD PhD Dana-Farber Dana-Farber News Dana-Farber’s Breast Oncology Center Dr. Beatrice Wiafe-Addai's visit truly highlights the global challenges in cancer care, particularly in regions like Ghana where resource limitations pose significant hurdles. It raises important questions about how advancements in treatment can be equitably accessed worldwide.

Congrats and well deserved Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸

What to look forward the most after ASCO Annual Meeting. The Harold J. Burstein, MD, PhD, FASCO #ASCO25 Highlights. Starting with differences between "formerly a big deal" vs "k of the moment" and its proof Sara Tolaney Dana-Farber’s Breast Oncology Center

The highly awaited Harold J. Burstein, MD, PhD, FASCO ASCO Highlights lecture once more delivers education, great food for thoughts and FUN! Dana-Farber’s Breast Oncology Center

Pratik Joshi had been living in London for six years. A software professional, he’d long dreamed of building a life abroad for his wife and three young children, who stayed back in India. After years of waiting for due clearances the dream was finally coming true. Just two days

Chemotherapy can save lives, but it can also come with challenges like #PeripheralNeuropathy. Ting Bao, MD, MS, (Ting Bao, MD) co-director of the Dana-Farber Zakim Center breaks down #ChemotherapyInducedPeripheralNeuropathy. Watch the webinar to learn about the causes, symptoms, risk

📢 Just out in Cancer Treatment Reviews! We explore a key challenge in HR+/HER2– BC: resistance to CDK4/6i. 💡 Why it happens 🔄 How to overcome it with combos 🚀 What’s next Proud of the great collaborative effort behind this work. 📖 doi.org/10.1016/j.ctrv…

A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environment. #bcsm knowablemagazine.org/content/articl…

Such a strong signal for our new partnership with BIDMC. You just got the best breast surgeon to lead the Program!

Congratulations to Dr. Filipa Lynce (Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸) recipient of the Women’s Health Collaboration Award from the Massachusetts Life Sciences Center! This award supports collaborative projects that aim to improve the discovery, technical innovation, and analysis of datasets to answer pressing life